TY - JOUR AU - Jones, J. C. AU - Rustagi, S. AU - Dempsey, P. J. PY - 2016 DA - 2016// TI - ADAM proteases and gastrointestinal function JO - Annu Rev Physiol VL - 78 UR - https://doi.org/10.1146/annurev-physiol-021014-071720 DO - 10.1146/annurev-physiol-021014-071720 ID - Jones2016 ER - TY - JOUR AU - Edwards, D. R. AU - Handsley, M. M. AU - Pennington, C. J. PY - 2008 DA - 2008// TI - The ADAM metalloproteinases JO - Mol Aspects Med VL - 29 UR - https://doi.org/10.1016/j.mam.2008.08.001 DO - 10.1016/j.mam.2008.08.001 ID - Edwards2008 ER - TY - JOUR AU - Tetering, G. AU - Diest, P. AU - Verlaan, I. AU - Wall, E. AU - Kopan, R. AU - Vooijs, M. PY - 2009 DA - 2009// TI - Metalloprotease ADAM10 is required for Notch1 site 2 cleavage JO - J Biol Chem VL - 284 UR - https://doi.org/10.1074/jbc.M109.006775 DO - 10.1074/jbc.M109.006775 ID - Tetering2009 ER - TY - JOUR AU - Blobel, C. P. PY - 2005 DA - 2005// TI - ADAMs: key components in EGFR signalling and development JO - Nature Rev Mol Cell Biol VL - 6 UR - https://doi.org/10.1038/nrm1548 DO - 10.1038/nrm1548 ID - Blobel2005 ER - TY - JOUR AU - Kataoka, H. PY - 2009 DA - 2009// TI - EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments JO - J Dermatol Sci VL - 56 UR - https://doi.org/10.1016/j.jdermsci.2009.10.002 DO - 10.1016/j.jdermsci.2009.10.002 ID - Kataoka2009 ER - TY - JOUR AU - Schaper, F. AU - Rose-John, S. PY - 2015 DA - 2015// TI - Interleukin-6: Biology, signaling and strategies of blockade JO - Cytokine Growth Factor Rev VL - 26 UR - https://doi.org/10.1016/j.cytogfr.2015.07.004 DO - 10.1016/j.cytogfr.2015.07.004 ID - Schaper2015 ER - TY - JOUR AU - Maney, S. K. AU - McIlwain, D. R. AU - Polz, R. AU - Pandyra, A. A. AU - Sundaram, B. AU - Wolff, D. PY - 2015 DA - 2015// TI - Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17 JO - Sci Signal VL - 8 UR - https://doi.org/10.1126/scisignal.aac5356 DO - 10.1126/scisignal.aac5356 ID - Maney2015 ER - TY - JOUR AU - Maretzky, T. AU - Reiss, K. AU - Ludwig, A. AU - Buchholz, J. AU - Scholz, F. AU - Proksch, E. PY - 2005 DA - 2005// TI - ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and β-catenin translocation JO - Proc Natl Acad Sci USA VL - 102 UR - https://doi.org/10.1073/pnas.0500918102 DO - 10.1073/pnas.0500918102 ID - Maretzky2005 ER - TY - JOUR AU - Hartmann, M. AU - Parra, L. M. AU - Ruschel, A. AU - Bohme, S. AU - Li, Y. AU - Morrison, H. PY - 2015 DA - 2015// TI - Tumor suppressor NF2 blocks cellular migration by inhibiting ectodomain cleavage of CD44 JO - Mol Cancer Res. VL - 13 UR - https://doi.org/10.1158/1541-7786.MCR-15-0020-T DO - 10.1158/1541-7786.MCR-15-0020-T ID - Hartmann2015 ER - TY - JOUR AU - Mullooly, M. AU - McGowan, P. AU - Crown, J. AU - Duffy, M. J. PY - 2016 DA - 2016// TI - The ADAMs family of proteases as targets for the treatment of cancer JO - Cancer Biol Ther. VL - 17 UR - https://doi.org/10.1080/15384047.2016.1177684 DO - 10.1080/15384047.2016.1177684 ID - Mullooly2016 ER - TY - JOUR AU - Lopez-Otin, C. AU - Hunter, T. PY - 2010 DA - 2010// TI - The regulatory crosstalk between kinases and proteases in cancer JO - Nat Rev Cancer VL - 10 ID - Lopez-Otin2010 ER - TY - JOUR AU - Murphy, G. PY - 2008 DA - 2008// TI - The ADAMs: signalling scissors in the tumour microenvironment JO - Nature Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2459 DO - 10.1038/nrc2459 ID - Murphy2008 ER - TY - JOUR AU - Kveiborg, M. AU - Frohlich, C. AU - Albrechtsen, R. AU - Tischler, V. AU - Dietrich, N. AU - Holck, P. PY - 2005 DA - 2005// TI - A role for ADAM12 in breast tumor progression and stromal cell apoptosis JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-0262 DO - 10.1158/0008-5472.CAN-05-0262 ID - Kveiborg2005 ER - TY - JOUR AU - Bertucci, F. AU - Finetti, P. AU - Cervera, N. AU - Charafe-Jauffret, E. AU - Mamessier, E. AU - Adelaide, J. PY - 2006 DA - 2006// TI - Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-0031 DO - 10.1158/0008-5472.CAN-06-0031 ID - Bertucci2006 ER - TY - JOUR AU - Wang, Y. AU - Klijn, J. G. AU - Zhang, Y. AU - Sieuwerts, A. M. AU - Look, M. P. AU - Yang, F. PY - 2005 DA - 2005// TI - Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)70933-8 DO - 10.1016/S0140-6736(05)70933-8 ID - Wang2005 ER - TY - JOUR AU - Li, H. AU - Duhachek-Muggy, S. AU - Qi, Y. AU - Hong, Y. AU - Behbod, F. AU - Zolkiewska, A. PY - 2012 DA - 2012// TI - An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer JO - Breast Cancer Res Treat VL - 135 UR - https://doi.org/10.1007/s10549-012-2220-4 DO - 10.1007/s10549-012-2220-4 ID - Li2012 ER - TY - JOUR AU - Ruff, M. AU - Leyme, A. AU - Cann, F. AU - Bonnier, D. AU - Seyec, J. AU - Chesnel, F. PY - 2015 DA - 2015// TI - The Disintegrin and metalloprotease ADAM12 is associated with TGF-β-induced epithelial to mesenchymal transition JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0139179 DO - 10.1371/journal.pone.0139179 ID - Ruff2015 ER - TY - JOUR AU - Li, H. AU - Duhachek-Muggy, S. AU - Dubnicka, S. AU - Zolkiewska, A. PY - 2013 DA - 2013// TI - Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype JO - Breast Cancer Res Treat VL - 139 UR - https://doi.org/10.1007/s10549-013-2602-2 DO - 10.1007/s10549-013-2602-2 ID - Li2013 ER - TY - JOUR AU - Prat, A. AU - Parker, J. S. AU - Karginova, O. AU - Fan, C. AU - Livasy, C. AU - Herschkowitz, J. I. PY - 2010 DA - 2010// TI - Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer JO - Breast Cancer Res VL - 12 UR - https://doi.org/10.1186/bcr2635 DO - 10.1186/bcr2635 ID - Prat2010 ER - TY - JOUR AU - Sabatier, R. AU - Finetti, P. AU - Guille, A. AU - Adelaide, J. AU - Chaffanet, M. AU - Viens, P. PY - 2014 DA - 2014// TI - Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-228 DO - 10.1186/1476-4598-13-228 ID - Sabatier2014 ER - TY - JOUR AU - Wei, W. AU - Tweardy, D. J. AU - Zhang, M. AU - Zhang, X. AU - Landua, J. AU - Petrovic, I. PY - 2014 DA - 2014// TI - STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer JO - Stem Cells VL - 32 UR - https://doi.org/10.1002/stem.1752 DO - 10.1002/stem.1752 ID - Wei2014 ER - TY - JOUR AU - Creighton, C. J. AU - Li, X. AU - Landis, M. AU - Dixon, J. M. AU - Neumeister, V. M. AU - Sjolund, A. PY - 2009 DA - 2009// TI - Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features JO - Proc Natl Acad Sci USA VL - 106 UR - https://doi.org/10.1073/pnas.0905718106 DO - 10.1073/pnas.0905718106 ID - Creighton2009 ER - TY - JOUR AU - Wei, W. AU - Lewis, M. T. PY - 2015 DA - 2015// TI - Identifying and targeting tumor-initiating cells in the treatment of breast cancer JO - Endocr Relat Cancer VL - 22 UR - https://doi.org/10.1530/ERC-14-0447 DO - 10.1530/ERC-14-0447 ID - Wei2015 ER - TY - JOUR AU - Colak, S. AU - Medema, J. P. PY - 2014 DA - 2014// TI - Cancer stem cells-important players in tumor therapy resistance JO - FEBS J VL - 281 UR - https://doi.org/10.1111/febs.13023 DO - 10.1111/febs.13023 ID - Colak2014 ER - TY - JOUR AU - Visvader, J. E. AU - Lindeman, G. J. PY - 2012 DA - 2012// TI - Cancer stem cells: current status and evolving complexities JO - Cell Stem Cell VL - 10 UR - https://doi.org/10.1016/j.stem.2012.05.007 DO - 10.1016/j.stem.2012.05.007 ID - Visvader2012 ER - TY - JOUR AU - Neve, R. M. AU - Chin, K. AU - Fridlyand, J. AU - Yeh, J. AU - Baehner, F. L. AU - Fevr, T. PY - 2006 DA - 2006// TI - A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes JO - Cancer Cell. VL - 10 UR - https://doi.org/10.1016/j.ccr.2006.10.008 DO - 10.1016/j.ccr.2006.10.008 ID - Neve2006 ER - TY - JOUR AU - Prat, A. AU - Karginova, O. AU - Parker, J. S. AU - Fan, C. AU - He, X. AU - Bixby, L. PY - 2013 DA - 2013// TI - Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes JO - Breast Cancer Res Treat VL - 142 UR - https://doi.org/10.1007/s10549-013-2743-3 DO - 10.1007/s10549-013-2743-3 ID - Prat2013 ER - TY - JOUR AU - Hollestelle, A. AU - Nagel, J. H. AU - Smid, M. AU - Lam, S. AU - Elstrodt, F. AU - Wasielewski, M. PY - 2010 DA - 2010// TI - Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines JO - Breast Cancer Res Treat VL - 121 UR - https://doi.org/10.1007/s10549-009-0460-8 DO - 10.1007/s10549-009-0460-8 ID - Hollestelle2010 ER - TY - JOUR AU - Barnabas, N. AU - Cohen, D. PY - 2013 DA - 2013// TI - Phenotypic and molecular characterization of MCF10DCIS and SUM breast cancer cell lines JO - Int J Breast Cancer VL - 2013 UR - https://doi.org/10.1155/2013/872743 DO - 10.1155/2013/872743 ID - Barnabas2013 ER - TY - JOUR AU - Qi, Y. AU - Duhachek-Muggy, S. AU - Li, H. AU - Zolkiewska, A. PY - 2014 DA - 2014// TI - Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12 JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0092536 DO - 10.1371/journal.pone.0092536 ID - Qi2014 ER - TY - JOUR AU - Vijver, M. J. AU - He, Y. D. AU - Veer, L. J. AU - Dai, H. AU - Hart, A. A. AU - Voskuil, D. W. PY - 2002 DA - 2002// TI - A gene-expression signature as a predictor of survival in breast cancer JO - N Engl J Med. VL - 347 UR - https://doi.org/10.1056/NEJMoa021967 DO - 10.1056/NEJMoa021967 ID - Vijver2002 ER - TY - JOUR AU - Harrell, J. C. AU - Prat, A. AU - Parker, J. S. AU - Fan, C. AU - He, X. AU - Carey, L. PY - 2012 DA - 2012// TI - Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse JO - Breast Cancer Res Treat. VL - 132 UR - https://doi.org/10.1007/s10549-011-1619-7 DO - 10.1007/s10549-011-1619-7 ID - Harrell2012 ER - TY - STD TI - Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61-70 ID - ref33 ER - TY - STD TI - Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:1. ID - ref34 ER - TY - JOUR AU - Cerami, E. AU - Gao, J. AU - Dogrusoz, U. AU - Gross, B. E. AU - Sumer, S. O. AU - Aksoy, B. A. PY - 2012 DA - 2012// TI - The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-12-0095 DO - 10.1158/2159-8290.CD-12-0095 ID - Cerami2012 ER - TY - JOUR AU - Lehmann, B. D. AU - Bauer, J. A. AU - Chen, X. AU - Sanders, M. E. AU - Chakravarthy, A. B. AU - Shyr, Y. PY - 2011 DA - 2011// TI - Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI45014 DO - 10.1172/JCI45014 ID - Lehmann2011 ER - TY - JOUR AU - Creighton, C. J. AU - Hilger, A. M. AU - Murthy, S. AU - Rae, J. M. AU - Chinnaiyan, A. M. AU - El-Ashry, D. PY - 2006 DA - 2006// TI - Activation of mitogen-activated protein kinase in estrogen receptor α-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor α-negative human breast tumors JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-4363 DO - 10.1158/0008-5472.CAN-05-4363 ID - Creighton2006 ER - TY - JOUR AU - Ciriello, G. AU - Gatza, M. L. AU - Beck, A. H. AU - Wilkerson, M. D. AU - Rhie, S. K. AU - Pastore, A. PY - 2015 DA - 2015// TI - Comprehensive molecular portraits of invasive lobular breast cancer JO - Cell VL - 163 UR - https://doi.org/10.1016/j.cell.2015.09.033 DO - 10.1016/j.cell.2015.09.033 ID - Ciriello2015 ER - TY - JOUR AU - Gyorffy, B. AU - Lanczky, A. AU - Eklund, A. C. AU - Denkert, C. AU - Budczies, J. AU - Li, Q. PY - 2010 DA - 2010// TI - An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients JO - Breast Cancer Res Treat. VL - 123 UR - https://doi.org/10.1007/s10549-009-0674-9 DO - 10.1007/s10549-009-0674-9 ID - Gyorffy2010 ER - TY - JOUR AU - Lehmann, B. D. AU - Pietenpol, J. A. PY - 2014 DA - 2014// TI - Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes JO - J Pathol. VL - 232 UR - https://doi.org/10.1002/path.4280 DO - 10.1002/path.4280 ID - Lehmann2014 ER - TY - JOUR AU - Subramanian, A. AU - Tamayo, P. AU - Mootha, V. K. AU - Mukherjee, S. AU - Ebert, B. L. AU - Gillette, M. A. PY - 2005 DA - 2005// TI - Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles JO - Proc Natl Acad Sci USA VL - 102 UR - https://doi.org/10.1073/pnas.0506580102 DO - 10.1073/pnas.0506580102 ID - Subramanian2005 ER - TY - JOUR AU - Duhachek-Muggy, S. AU - Zolkiewska, A. PY - 2015 DA - 2015// TI - ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1108-1 DO - 10.1186/s12885-015-1108-1 ID - Duhachek-Muggy2015 ER - TY - JOUR AU - Fillmore, C. M. AU - Kuperwasser, C. PY - 2008 DA - 2008// TI - Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy JO - Breast Cancer Re VL - 10 UR - https://doi.org/10.1186/bcr1982 DO - 10.1186/bcr1982 ID - Fillmore2008 ER - TY - JOUR AU - Hu, Y. AU - Smyth, G. K. PY - 2009 DA - 2009// TI - ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays JO - J Immunol Methods VL - 347 UR - https://doi.org/10.1016/j.jim.2009.06.008 DO - 10.1016/j.jim.2009.06.008 ID - Hu2009 ER - TY - JOUR AU - Zwang, Y. AU - Sas-Chen, A. AU - Drier, Y. AU - Shay, T. AU - Avraham, R. AU - Lauriola, M. PY - 2011 DA - 2011// TI - Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals JO - Mol Cell. VL - 42 UR - https://doi.org/10.1016/j.molcel.2011.04.017 DO - 10.1016/j.molcel.2011.04.017 ID - Zwang2011 ER - TY - JOUR AU - Bild, A. H. AU - Yao, G. AU - Chang, J. T. AU - Wang, Q. AU - Potti, A. AU - Chasse, D. PY - 2006 DA - 2006// TI - Oncogenic pathway signatures in human cancers as a guide to targeted therapies JO - Nature VL - 439 UR - https://doi.org/10.1038/nature04296 DO - 10.1038/nature04296 ID - Bild2006 ER - TY - JOUR AU - Kramer, A. AU - Green, J. AU - Pollard, J. AU - Tugendreich, S. PY - 2014 DA - 2014// TI - Causal analysis approaches in Ingenuity Pathway Analysis JO - Bioinformatics. VL - 30 UR - https://doi.org/10.1093/bioinformatics/btt703 DO - 10.1093/bioinformatics/btt703 ID - Kramer2014 ER - TY - JOUR AU - Farnie, G. AU - Clarke, R. B. AU - Spence, K. AU - Pinnock, N. AU - Brennan, K. AU - Anderson, N. G. PY - 2007 DA - 2007// TI - Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways JO - J Natl Cancer Inst VL - 99 UR - https://doi.org/10.1093/jnci/djk133 DO - 10.1093/jnci/djk133 ID - Farnie2007 ER - TY - JOUR AU - Tanei, T. AU - Choi, D. S. AU - Rodriguez, A. A. AU - Liang, D. H. AU - Dobrolecki, L. AU - Ghosh, M. PY - 2016 DA - 2016// TI - Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells JO - Breast Cancer Res VL - 18 UR - https://doi.org/10.1186/s13058-015-0662-4 DO - 10.1186/s13058-015-0662-4 ID - Tanei2016 ER - TY - JOUR AU - Oliveras-Ferraros, C. AU - Vazquez-Martin, A. AU - Cufi, S. AU - Queralt, B. AU - Baez, L. AU - Guardeno, R. PY - 2011 DA - 2011// TI - Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux) efficacy in KRAS wild-type tumor cells JO - J Cell Biochem VL - 112 UR - https://doi.org/10.1002/jcb.22952 DO - 10.1002/jcb.22952 ID - Oliveras-Ferraros2011 ER - TY - JOUR AU - Abhold, E. L. AU - Kiang, A. AU - Rahimy, E. AU - Kuo, S. Z. AU - Wang-Rodriguez, J. AU - Lopez, J. P. PY - 2012 DA - 2012// TI - EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0032459 DO - 10.1371/journal.pone.0032459 ID - Abhold2012 ER - TY - JOUR AU - Leong, H. S. AU - Chong, F. T. AU - Sew, P. H. AU - Lau, D. P. AU - Wong, B. H. AU - Teh, B. T. PY - 2014 DA - 2014// TI - Targeting cancer stem cell plasticity through modulation of epidermal growth factor and insulin-like growth factor receptor signaling in head and neck squamous cell cancer JO - Stem Cells Transl Med. VL - 3 UR - https://doi.org/10.5966/sctm.2013-0214 DO - 10.5966/sctm.2013-0214 ID - Leong2014 ER - TY - JOUR AU - Ma, L. AU - Zhang, G. AU - Miao, X. B. AU - Deng, X. B. AU - Wu, Y. AU - Liu, Y. PY - 2013 DA - 2013// TI - Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma JO - FEBS J. VL - 280 UR - https://doi.org/10.1111/febs.12226 DO - 10.1111/febs.12226 ID - Ma2013 ER - TY - JOUR AU - Balko, J. M. AU - Schwarz, L. J. AU - Bhola, N. E. AU - Kurupi, R. AU - Owens, P. AU - Miller, T. W. PY - 2013 DA - 2013// TI - Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer JO - Cancer Res. VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-13-1385 DO - 10.1158/0008-5472.CAN-13-1385 ID - Balko2013 ER - TY - JOUR AU - Blobel, C. P. PY - 2005 DA - 2005// TI - ADAMs: key components in EGFR signalling and development JO - Nat Rev Mol Cell Biol VL - 6 UR - https://doi.org/10.1038/nrm1548 DO - 10.1038/nrm1548 ID - Blobel2005 ER - TY - JOUR AU - Kenny, P. A. AU - Bissell, M. J. PY - 2007 DA - 2007// TI - Targeting TACE-dependent EGFR ligand shedding in breast cancer JO - J Clin Invest VL - 117 UR - https://doi.org/10.1172/JCI29518 DO - 10.1172/JCI29518 ID - Kenny2007 ER - TY - JOUR AU - Kenny, P. A. PY - 2007 DA - 2007// TI - TACE: a new target in epidermal growth factor receptor dependent tumors JO - Differentiation VL - 75 UR - https://doi.org/10.1111/j.1432-0436.2007.00198.x DO - 10.1111/j.1432-0436.2007.00198.x ID - Kenny2007 ER - TY - JOUR AU - Giricz, O. AU - Calvo, V. AU - Peterson, E. A. AU - Abouzeid, C. M. AU - Kenny, P. A. PY - 2013 DA - 2013// TI - TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion JO - Int J Cancer VL - 133 ID - Giricz2013 ER - TY - JOUR AU - Asakura, M. AU - Kitakaze, M. AU - Takashima, S. AU - Liao, Y. AU - Ishikura, F. AU - Yoshinaka, T. PY - 2002 DA - 2002// TI - Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy JO - Nat Med. VL - 8 UR - https://doi.org/10.1038/nm0102-35 DO - 10.1038/nm0102-35 ID - Asakura2002 ER - TY - JOUR AU - Diaz, B. AU - Yuen, A. AU - Iizuka, S. AU - Higashiyama, S. AU - Courtneidge, S. A. PY - 2013 DA - 2013// TI - Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia JO - J Cell Biol VL - 201 UR - https://doi.org/10.1083/jcb.201209151 DO - 10.1083/jcb.201209151 ID - Diaz2013 ER - TY - JOUR AU - Singh, A. AU - Settleman, J. PY - 2010 DA - 2010// TI - EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.215 DO - 10.1038/onc.2010.215 ID - Singh2010 ER - TY - STD TI - Nistico P, Bissell MJ, Radisky DC. Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. Cold Spring Harb Perspect Biol. 2012;4:a011908. ID - ref62 ER - TY - JOUR AU - Turner, N. C. AU - Reis-Filho, J. S. PY - 2013 DA - 2013// TI - Tackling the diversity of triple-negative breast cancer JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-13-0915 DO - 10.1158/1078-0432.CCR-13-0915 ID - Turner2013 ER - TY - JOUR AU - Corkery, B. AU - Crown, J. AU - Clynes, M. AU - O'Donovan, N. PY - 2009 DA - 2009// TI - Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn710 DO - 10.1093/annonc/mdn710 ID - Corkery2009 ER - TY - JOUR AU - Hoadley, K. A. AU - Weigman, V. J. AU - Fan, C. AU - Sawyer, L. R. AU - He, X. AU - Troester, M. A. PY - 2007 DA - 2007// TI - EGFR associated expression profiles vary with breast tumor subtype JO - BMC Genomics VL - 8 UR - https://doi.org/10.1186/1471-2164-8-258 DO - 10.1186/1471-2164-8-258 ID - Hoadley2007 ER - TY - JOUR AU - Carey, L. A. AU - Rugo, H. S. AU - Marcom, P. K. AU - Mayer, E. L. AU - Esteva, F. J. AU - Ma, C. X. PY - 2012 DA - 2012// TI - TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer JO - J Clin Oncol. VL - 30 UR - https://doi.org/10.1200/JCO.2010.34.5579 DO - 10.1200/JCO.2010.34.5579 ID - Carey2012 ER - TY - JOUR AU - Baselga, J. AU - Gomez, P. AU - Greil, R. AU - Braga, S. AU - Climent, M. A. AU - Wardley, A. M. PY - 2013 DA - 2013// TI - Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer JO - J Clin Oncol. VL - 31 UR - https://doi.org/10.1200/JCO.2012.46.2408 DO - 10.1200/JCO.2012.46.2408 ID - Baselga2013 ER - TY - JOUR AU - Williams, C. B. AU - Soloff, A. C. AU - Ethier, S. P. AU - Yeh, E. S. PY - 2015 DA - 2015// TI - Perspectives on epidermal growth factor receptor regulation in triple-negative breast cancer: Ligand-mediated mechanisms of receptor regulation and potential for clinical targeting JO - Adv Cancer Res. VL - 127 UR - https://doi.org/10.1016/bs.acr.2015.04.008 DO - 10.1016/bs.acr.2015.04.008 ID - Williams2015 ER - TY - JOUR AU - Masuda, H. AU - Zhang, D. AU - Bartholomeusz, C. AU - Doihara, H. AU - Hortobagyi, G. N. AU - Ueno, N. T. PY - 2012 DA - 2012// TI - Role of epidermal growth factor receptor in breast cancer JO - Breast Cancer Res Treat. VL - 136 UR - https://doi.org/10.1007/s10549-012-2289-9 DO - 10.1007/s10549-012-2289-9 ID - Masuda2012 ER -